Lexicon Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of LXRX for the last quarter is 1.13 M USD, and it's 60.97% higher compared to the previous quarter. The net income of Q1 24 is -48.40 M USD.